Related references
Note: Only part of the references are listed.Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression
Seung-Myoung Son et al.
MODERN PATHOLOGY (2017)
Sporadic Porphyria Cutanea Tarda Induced by Alcohol Abuse
Xiu-Min Yang et al.
CHINESE MEDICAL JOURNAL (2017)
High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma
Allison Rosenthal et al.
BLOOD REVIEWS (2017)
Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma
Cristiano Claudino Oliveira et al.
DIAGNOSTIC PATHOLOGY (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
Christiane Copie-Bergman et al.
BLOOD (2015)
B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas
Shaoying Li et al.
MODERN PATHOLOGY (2015)
Immunoglobulin Repertoire of Primary Lymphomas of the Central Nervous System
Manuel Montesinos-Rongen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov et al.
MODERN PATHOLOGY (2014)
MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Li-Xu Yan et al.
PLOS ONE (2014)
Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYClowBCL2low subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas
Anna Brunn et al.
ACTA NEUROPATHOLOGICA (2013)
MYC rearrangements are useful for predicting outcomes following rituximab and chemotherapy: multicenter analysis of Japanese patients with diffuse large B-cell lymphoma
Minoru Kojima et al.
LEUKEMIA & LYMPHOMA (2013)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series
Sawyna Provencher et al.
HEMATOLOGICAL ONCOLOGY (2011)
Primary central nervous system lymphoma: Immunohistochemical profile and prognostic significance
Delphine Raoux et al.
NEUROPATHOLOGY (2010)
Insights Into the Biology of Primary Central Nervous System Lymphoma
Maciej M. Mrugala et al.
CURRENT ONCOLOGY REPORTS (2009)
Del(6)(q22) and BCL6 Rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course
Francois M. Cady et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell
M. Montesinos-Rongen et al.
LEUKEMIA (2008)
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
J. Iqbal et al.
LEUKEMIA (2007)
Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination
Heinrich Schwindt et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system
M Montesinos-Rongen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Share Paper
